Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Aguilar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Therapeutics|June 4, 2011
Evaluating treatment algorithms for the management of patients with type 2 diabetes mellitus: a perspective on the definition of treatment successRichard B Aguilar
Cleveland Clinic Journal of Medicine|July 11, 2019
Type 2 diabetes: Evolving concepts and treatmentEden Miller, Richard B Aguilar, Mary E Herman, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trialsJaime A Davidson, Rosemarie Lajara, Richard B Aguilar, et al.
Diabetes Care|January 23, 2016
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification SchemaStanley S Schwartz, Solomon Epstein, Barbara E Corkey, et al.
Diabetes Care|July 27, 2016
Response to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. Diabetes Care 2016;39:179-186Stanley S Schwartz, Solomon Epstein, Barbara E Corkey, et al.
The American Journal of Managed Care|June 22, 2021
Managed care COVID-19 outcomes in a population health programRichard B Aguilar, Patrick Hardigan, Bindu S Mayi, et al.
Trends in Endocrinology and Metabolism: TEM|June 21, 2017
A Unified Pathophysiological Construct of Diabetes and its ComplicationsStanley S Schwartz, Solomon Epstein, Barbara E Corkey, et al.
Frontiers in Medicine|November 16, 2020
Current Understanding of COVID-19 Clinical Course and Investigational TreatmentsRichard B Aguilar, Patrick Hardigan, Bindu Mayi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Therapeutics|June 4, 2011
Evaluating treatment algorithms for the management of patients with type 2 diabetes mellitus: a perspective on the definition of treatment successRichard B Aguilar
Cleveland Clinic Journal of Medicine|July 11, 2019
Type 2 diabetes: Evolving concepts and treatmentEden Miller, Richard B Aguilar, Mary E Herman, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trialsJaime A Davidson, Rosemarie Lajara, Richard B Aguilar, et al.
Diabetes Care|January 23, 2016
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification SchemaStanley S Schwartz, Solomon Epstein, Barbara E Corkey, et al.
Diabetes Care|July 27, 2016
Response to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. Diabetes Care 2016;39:179-186Stanley S Schwartz, Solomon Epstein, Barbara E Corkey, et al.
The American Journal of Managed Care|June 22, 2021
Managed care COVID-19 outcomes in a population health programRichard B Aguilar, Patrick Hardigan, Bindu S Mayi, et al.
Trends in Endocrinology and Metabolism: TEM|June 21, 2017
A Unified Pathophysiological Construct of Diabetes and its ComplicationsStanley S Schwartz, Solomon Epstein, Barbara E Corkey, et al.
Frontiers in Medicine|November 16, 2020
Current Understanding of COVID-19 Clinical Course and Investigational TreatmentsRichard B Aguilar, Patrick Hardigan, Bindu Mayi, et al.
Pageof 1